Robert Britton

Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert Britton is a Professor at Baylor College of Medicine in the United States. His research focuses on microbiome-targeting therapeutics, gastrointestinal health, and the interaction between microbial communities and host biology. Recent publications include studies on the therapeutic potential of Limosilactobacillus reuteri and the metabolic phenotypes of Clostridioides difficile, highlighting advancements in microbial biosensors and automated analysis software.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Britton

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes

Limosilactobacillus reuteri promotes the expression and secretion of enteroendocrine‐ and enterocyte‐derived hormones

Limosilactobacillus reuteri enables oral-to-systemic absorption of iberiotoxin for treatment of collagen-induced arthritis in rats

Microbial Biosensor for Sensing and Treatment of Intestinal Inflammation

Present and future of microbiome-targeting therapeutics

Control of Clostridioides difficile virulence and physiology by the flagellin homeostasis checkpoint FliC-FliW-CsrA in the absence of motility

Taking Microbiome Science to the Next Level: Recommendations to Advance the Emerging Field of Microbiome-Based Therapeutics and Diagnostics

AMiGA: Software for Automated Analysis of Microbial Growth Assays

AMiGA: Software for Automated Analysis of Microbial Growth Assays

Discovery of a bacterial peptide as a modulator of GLP-1 and metabolic disease.

Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation

Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction

Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction

Collaborators (5)

Frank Horrigan

Sara Di Rienzi

Firas Midani

James Collins

Kevin W. Garey

Make your next move.